title: Expression of functional melatonin MT(1) receptors in equine luteal cells: in vitro effects of melatonin on progesterone secretion.
abstract: In the present study, we analysed the molecular mechanism(s) by which melatonin directly affects ovarian function in the mare. In Experiment 1, follicles and corpora lutea (CL) were collected from slaughterhouse ovaries and analysed for melatonin (MT(1)) receptor mRNA and protein. In Experiment 2, CL were collected from slaughterhouse ovaries and cultured in Dulbecco's modified Eagle's medium-F12 medium (control medium) supplemented with 50 ng mL(-1) equine chorionic gonadotrophin (eCG), 1 nM-1 μM melatonin, 1 μM forskolin or 1 μM luzindole. Explants were cultured for 3 h in the presence of these drugs. Conditioned media were analysed for progesterone production; luteal cells were analysed for cholesterol side-chain cleavage enzyme (P450scc), a steroidogenic enzyme that converts cholesterol into pregnenolone. Both MT(1) receptor mRNA and protein were expressed in follicles and CL. Melatonin inhibited both the eCG- and forskolin-stimulated production of progesterone, as well as the forskolin-stimulated expression of P450scc, in equine luteal cells and the effect was dose-dependent. The inhibitory effect of melatonin was blocked by luzindole, a non-selective melatonin MT(1) and MT(2) receptor antagonist. The data support the presence of functional melatonin receptors in luteal cells and a regulatory role for melatonin in the endocrine function of the equine CL.
authors.affiliation: Facultad de Medicina Veterinaria, Universidad San Sebastián, General Cruz N° 1577, Concepción, Chile.
authors.forename: Marcos
authors.initials: M
authors.lastname: Pedreros
authors.forename: Marcelo
authors.initials: M
authors.lastname: Ratto
authors.forename: Montserrat
authors.initials: M
authors.lastname: Guerra
mesh_terms: D000818:Animals; D015153:Blotting, Western / Q000662:veterinary; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000096:biosynthesis / Q000378:metabolism; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology; D005260:Female; D006736:Horses / Q000502:physiology*; D008184:Luteal Cells / Q000187:drug effects* / Q000378:metabolism*; D008550:Melatonin / Q000494:pharmacology*; D006080:Ovarian Follicle / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D011374:Progesterone / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D044122:Receptor, Melatonin, MT1 / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000662:veterinary; D018709:Statistics, Nonparametric; D014363:Tryptamines / Q000494:pharmacology
chemical_list: D006063:Chorionic Gonadotropin; D012333:RNA, Messenger; D044122:Receptor, Melatonin, MT1; D014363:Tryptamines; C057154:luzindole; D005576:Colforsin; D011374:Progesterone; D002786:Cholesterol Side-Chain Cleavage Enzyme; D008550:Melatonin